Broader indices haven't been performing very well since the Fed's not so surprise revelation about the number of expected cuts in 2025. Nevertheless, several stocks on Thursday posted notable gains. Let's take a look:
10. Summit Therapeutics Inc. (SMMT)
Shares of Summit Therapeutics (SMMT) on Thursday closed higher by 8.36 percent at $18.40 apiece as traders took heart from news that the company—in partnership with Chinese biotech Akeso—is developing a lung cancer treatment drug...
Create a free account or log in to unlock the full article and explore our stock research
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.